All studies
Ongoing, recruitingHuman Pharmacology (Phase I)- OtherInterventional

A study in healthy men to test how BI 1584862 is processed in the body

This study is looking at how a new medicine, called BI 1584862, is used and removed by the body. This is a very early stage of testing new medicines, often called a Phase 1 study. The researchers want to find out how the medicine works in healthy men. This type of study is really important because it helps scientists understand if a new medicine is safe enough to be tested in people with illnesses. By studying how the body handles the medicine, they can work out the best ways to give it and what effects it might have. This information is a crucial first step before the medicine can be developed further and potentially help many patients in the future.

At a glance

Status
Ongoing, recruiting
Phase
Human Pharmacology (Phase I)- Other
Sponsor
Boehringer Ingelheim International GmbH
Enrolment target
8
Start
10 Dec 2025

What is this study about?

This study is a very early step in checking new medicines. Researchers are testing a medicine called BI 1584862 in healthy men. The main goal is to see exactly how this medicine moves through the body. This includes understanding how the body takes it in, where it goes, how it changes, and how it eventually leaves the body. This is often called studying the "pharmacology" of a drug, which is just a fancy way of saying how the body and the medicine interact.

Think of it like learning how a new fuel works in an engine. You'd want to know how much fuel is used, what by-products are made, and how efficiently it runs. Similarly, for a new medicine, understanding these steps is vital. It helps scientists work out if the medicine is behaving as expected, if it's staying in the body for the right amount of time, and if there are any early signs of it causing problems.

This kind of research is really important because it helps scientists decide if a medicine is safe enough and works well enough to be tested further in people who actually have the condition the medicine is meant to treat. Without these early studies in healthy volunteers, it would be much harder and less safe to develop new treatments. It's a foundational step that paves the way for future medical advancements.

Key takeaways

  • This is an early study in healthy men for a new medicine.
  • It helps researchers understand how the body processes the new medicine.
  • Participation will involve clinic visits and taking the study medicine.
  • It contributes to developing future medicines.
  • You can withdraw from the study at any time.

Who may be eligible?

This study is looking for volunteers who are healthy men. You should be at least 18 years old or older. There is no upper age limit, but you will need to be in good general health.

Because this is a very early study of a new medicine, it's really important that participants are otherwise healthy. This helps the researchers understand the effects of the medicine itself without other health conditions getting in the way.

To make sure you are healthy enough, doctors and nurses will do a full health check before you can join the study. They will also look at your medical history and current health to confirm you meet all the requirements.

Quick self-check
  • Are you a man?
  • Are you 18 years old or older?
  • Do you consider yourself generally healthy?
  • Are you available to attend all required clinic visits?

This is a guide only — the research team will confirm whether you can take part.

What does participation involve?

If you decide to take part in this study, you will likely need to visit a clinic or research centre several times. During these visits, doctors and nurses will monitor your health closely. This will involve things like having blood samples taken, checking your heart rate and blood pressure, and answering questions about how you feel.

You will be given the study medicine, BI 1584862, usually as a single dose or a few doses over a short period. The way you receive the medicine (e.g., as a tablet or injection) will be explained to you. You'll be asked to follow specific instructions, like not eating certain foods or drinks, to ensure the medicine's effects are clear.

The overall time commitment for this type of study can vary, but it often involves a period of staying at the research centre for a few days, followed by some outpatient visits. The team will provide a detailed schedule covering all assessments, follow-up, and the total duration of your involvement.

Potential risks and benefits

Taking part in any study involves both possible benefits and potential risks. A potential benefit is contributing to medical science and helping develop new medicines that could help many people in the future. You will also receive careful medical checks throughout your involvement. Possible risks could include side effects from the study medicine, which will be fully explained before you agree to take part. These might be mild, like a headache, or could, in rare cases, be more serious. All risks will be discussed in detail, and doctors will be on hand to ensure your safety. Remember, you can choose to leave the study at any time, for any reason, without it affecting your usual medical care.

Locations (1)

  • Netherlands

Common questions

What does 'healthy volunteer trial' mean?

It means the study is looking for people who don't have any major health problems, so researchers can see how the new medicine affects a healthy body.

What is BI 1584862?

BI 1584862 is the special code name for a new medicine that is being tested. We don't know what it's for at this very early stage, just how people's bodies handle it.

Why is this study only for men?

Sometimes, early studies focus on one gender to simplify the research and understand the medicine's effects without potential differences between men and women affecting the results. Later studies might include women.

Will I get paid for taking part?

Many early-stage healthy volunteer studies offer payment for your time and inconvenience. This will be discussed with you before you agree to take part.

What happens after this study finishes?

The information gathered from this study will help scientists decide if BI 1584862 is safe and promising enough to move on to the next stages of testing, potentially in people with specific illnesses.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.